Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi.

Hollis A.

Healthc Policy. 2019 Aug;15(1):70-80. doi: 10.12927/hcpol.2019.25937.

PMID:
31629457
2.

Behavioural and cardiovascular effects of medetomidine constant rate infusion compared with detomidine for standing sedation in horses.

Hollis AR, Pascal M, Van Dijk J, Jolliffe C, Kaartinen J.

Vet Anaesth Analg. 2019 Sep 3. pii: S1467-2987(19)30201-6. doi: 10.1016/j.vaa.2019.06.009. [Epub ahead of print]

PMID:
31619335
3.

How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?

Beall RF, Hardcastle L, Clement F, Hollis A.

Health Policy. 2019 Sep 20. pii: S0168-8510(19)30225-8. doi: 10.1016/j.healthpol.2019.09.005. [Epub ahead of print]

PMID:
31601457
4.

Delays in diagnosis of nephrotic syndrome in children: A survey study.

Hollis A, Dart A, Morgan C, Mammen C, Zappitelli M, Chanchlani R, Samuel S.

Paediatr Child Health. 2019 Jul;24(4):258-262. doi: 10.1093/pch/pxy165. Epub 2018 Dec 28.

PMID:
31239815
5.

Validation of the NUn score as a predictor of anastomotic leak and major complications after Esophagectomy.

Bundred J, Hollis AC, Hodson J, Hallissey MT, Whiting JL, Griffiths EA.

Dis Esophagus. 2019 May 10. pii: doz041. doi: 10.1093/dote/doz041. [Epub ahead of print]

PMID:
31076741
6.

Recreational 'mud fever': Leptospira interrogans induced diffuse alveolar hemorrhage and severe acute respiratory distress syndrome in a U.S. Navy seaman following 'mud-run' in Hawaii.

Schmalzle SA, Tabatabai A, Mazzeffi M, Matta A, Hollis A, Zubrow M, Rajagopal K, Thom K, Scalea T.

IDCases. 2019 Mar 23;15:e00529. doi: 10.1016/j.idcr.2019.e00529. eCollection 2019.

7.

The impact of pharmaceutical rebates on patients' drug expenditures.

Memedovich KA, Manns B, Beall R, Hollis A, Clement F.

CMAJ. 2019 Mar 18;191(11):E308-E312. doi: 10.1503/cmaj.181041. No abstract available.

PMID:
30885969
8.

Use of the MMSE in the Prediction of Driving Fitness: Relevance of Specific Subtests.

O'Connor MG, Duncanson H, Hollis AM.

J Am Geriatr Soc. 2019 Apr;67(4):790-793. doi: 10.1111/jgs.15772. Epub 2019 Feb 8.

PMID:
30737774
9.

Computed tomographic dimensions of the normal adult equine eye.

Hollis AR, Dixon JJ, Berlato D, Murray R, Weller R.

Vet Ophthalmol. 2019 Sep;22(5):651-659. doi: 10.1111/vop.12636. Epub 2019 Feb 4.

PMID:
30716192
10.

Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: A cohort study.

Menaker J, Galvagno S, Rabinowitz R, Penchev V, Hollis A, Kon Z, Deatrick K, Amoroso A, Herr D, Mazzeffi M.

Heart Lung. 2019 May - Jun;48(3):236-239. doi: 10.1016/j.hrtlng.2019.01.004. Epub 2019 Jan 24.

PMID:
30686618
11.

Estimating the clinical cost of drug development for orphan versus non-orphan drugs.

Jayasundara K, Hollis A, Krahn M, Mamdani M, Hoch JS, Grootendorst P.

Orphanet J Rare Dis. 2019 Jan 10;14(1):12. doi: 10.1186/s13023-018-0990-4.

12.

In defense of Canada's drug plan managers.

Hollis A.

CMAJ. 2018 Jun 25;190(25):E771-E772. doi: 10.1503/cmaj.69951. No abstract available.

13.

Vascular type 1 angiotensin receptors control blood pressure by augmenting peripheral vascular resistance in female mice.

Wolf E, Diaz EJ, Hollis AN, Hoang TA, Azad HA, Bendt KM, Griffiths RC, Sparks MA.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F997-F1005. doi: 10.1152/ajprenal.00639.2017. Epub 2018 Jun 13.

14.

Prognostic significance of circumferential resection margin involvement in patients receiving potentially curative treatment for oesophageal cancer.

Quinn LM, Hollis AC, Hodson J, Elshafie MA, Hallissey MT, Whiting JL, Griffiths EA.

Eur J Surg Oncol. 2018 Aug;44(8):1268-1277. doi: 10.1016/j.ejso.2018.05.017. Epub 2018 May 17.

PMID:
29843937
15.

MicroRNAs in equine veterinary science.

Hollis AR, Starkey MP.

Equine Vet J. 2018 Nov;50(6):721-726. doi: 10.1111/evj.12954. Epub 2018 May 12. Review.

PMID:
29672919
16.

Understanding the factors that influence patient participation in Orthopaedic Clinical Trials.

Hollis AC, Davis ET.

Int Orthop. 2018 Aug;42(8):1769-1774. doi: 10.1007/s00264-018-3890-2. Epub 2018 Mar 20.

PMID:
29560527
17.

Errors versus speed on the trail making test: Relevance to driving performance.

Duncanson H, Hollis AM, O'Connor MG.

Accid Anal Prev. 2018 Apr;113:125-130. doi: 10.1016/j.aap.2018.01.004. Epub 2018 Mar 7.

PMID:
29407659
18.

Prostacyclins in Cardiac Surgery: Coming of Age.

Deshpande SP, Mazzeffi MA, Strauss E, Hollis A, Tanaka KA.

Semin Cardiothorac Vasc Anesth. 2018 Sep;22(3):306-323. doi: 10.1177/1089253217749298. Epub 2017 Dec 25. Review.

PMID:
29277148
19.

Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles?

Hollis A.

Expert Opin Ther Pat. 2018 Jan;28(1):1-3. doi: 10.1080/13543776.2018.1388780. Epub 2017 Oct 13. No abstract available.

PMID:
28974123
20.

Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer.

Hollis AC, Quinn LM, Hodson J, Evans E, Plowright J, Begum R, Mitchell H, Hallissey MT, Whiting JL, Griffiths EA.

J Surg Oncol. 2017 Dec;116(8):1114-1122. doi: 10.1002/jso.24789. Epub 2017 Aug 2.

PMID:
28767142
21.

Metabolic differences between cold stored and machine perfused porcine kidneys: A 1H NMR based study.

Nath J, Smith TB, Patel K, Ebbs SR, Hollis A, Tennant DA, Ludwig C, Ready AR.

Cryobiology. 2017 Feb;74:115-120. doi: 10.1016/j.cryobiol.2016.11.006. Epub 2016 Dec 3.

PMID:
27919740
22.

(13)C glucose labelling studies using 2D NMR are a useful tool for determining ex vivo whole organ metabolism during hypothermic machine perfusion of kidneys.

Nath J, Smith T, Hollis A, Ebbs S, Canbilen SW, Tennant DA, Ready AR, Ludwig C.

Transplant Res. 2016 Aug 5;5:7. doi: 10.1186/s13737-016-0037-0. eCollection 2016.

23.

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.

Hollis AL, Lowery AV, Pajoumand M, Pham SM, Slejko JF, Tanaka KA, Mazzeffi M.

Ann Card Anaesth. 2016 Jul-Sep;19(3):418-24. doi: 10.4103/0971-9784.185523.

24.

An examination of inpatient medical record keeping in the Orthopaedic Department of Kilimanjaro Christian Medical Centre (KCMC), Moshi, Tanzania.

Hollis AC, Ebbs SR.

Pan Afr Med J. 2016 Apr 20;23:207. doi: 10.11604/pamj.2016.23.207.8083. eCollection 2016.

25.

RNAi Screen Identifies Novel Regulators of RNP Granules in the Caenorhabditis elegans Germ Line.

Wood MP, Hollis A, Severance AL, Karrick ML, Schisa JA.

G3 (Bethesda). 2016 Aug 9;6(8):2643-54. doi: 10.1534/g3.116.031559.

26.

Sustainable Financing of Innovative Therapies: A Review of Approaches.

Hollis A.

Pharmacoeconomics. 2016 Oct;34(10):971-80. doi: 10.1007/s40273-016-0416-x. Review.

PMID:
27251182
27.

Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem.

Hollis A, Grootendorst P.

Healthc Policy. 2015 Aug;11(1):10-4.

28.

Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass.

Hollis AL, Heil EL, Nicolau DP, Odonkor P, Dowling TC, Thom KA.

Surg Infect (Larchmt). 2015 Dec;16(6):829-32. doi: 10.1089/sur.2014.250. Epub 2015 Aug 20.

PMID:
26291478
29.

Tier 3 multidisciplinary medical weight management improves outcome of Roux-en-Y gastric bypass surgery.

Patel P, Hartland A, Hollis A, Ali R, Elshaw A, Jain S, Khan A, Mirza S.

Ann R Coll Surg Engl. 2015 Apr;97(3):235-7. doi: 10.1308/003588414X14055925061838.

30.

Antibiotic Resistance Is a Tragedy of the Commons That Necessitates Global Cooperation.

Hollis A, Maybarduk P.

J Law Med Ethics. 2015 Summer;43 Suppl 3:33-7. doi: 10.1111/jlme.12272.

PMID:
26243241
31.

Generic drugs in Canada: an examination of tiered pricing.

Hollis A.

CMAJ. 2015 Oct 6;187(14):1033-1034. doi: 10.1503/cmaj.150395. Epub 2015 Jul 13. No abstract available.

32.

Validity of the mini-mental state examination and the montreal cognitive assessment in the prediction of driving test outcome.

Hollis AM, Duncanson H, Kapust LR, Xi PM, O'Connor MG.

J Am Geriatr Soc. 2015 May;63(5):988-92. doi: 10.1111/jgs.13384. Epub 2015 May 4.

PMID:
25940275
33.

Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy.

Roberts EA, Herder M, Hollis A.

CMAJ. 2015 Apr 7;187(6):422-425. doi: 10.1503/cmaj.140308. Epub 2015 Feb 23. Review. No abstract available.

34.

The epidemiology and treatment of femur fractures at a northern Tanzanian referral centre.

Hollis AC, Ebbs SR, Mandari FN.

Pan Afr Med J. 2015 Dec 4;22:338. doi: 10.11604/pamj.2015.22.338.8074. eCollection 2015.

35.

The path of least resistance: paying for antibiotics in non-human uses.

Hollis A, Ahmed Z.

Health Policy. 2014 Nov;118(2):264-70. doi: 10.1016/j.healthpol.2014.08.013. Epub 2014 Sep 8.

PMID:
25240271
36.

Price-cap Regulation, Uncertainty and the Price Evolution of New Pharmaceuticals.

Shajarizadeh A, Hollis A.

Health Econ. 2015 Aug;24(8):966-77. doi: 10.1002/hec.3075. Epub 2014 Jul 2.

PMID:
24990225
37.

An investigation into dental anxiety amongst paediatric cardiology patients.

Hollis A, Willcoxson F, Smith A, Balmer R.

Int J Paediatr Dent. 2015 May;25(3):183-90. doi: 10.1111/ipd.12111. Epub 2014 Jun 11.

PMID:
24916764
38.

Delays in the submission of new drugs in Canada.

Shajarizadeh A, Hollis A.

CMAJ. 2015 Jan 6;187(1):E47-E51. doi: 10.1503/cmaj.130814. Epub 2014 May 12. Review. No abstract available.

39.

Synthetic biology: ensuring the greatest global value.

Hollis A.

Syst Synth Biol. 2013 Sep;7(3):99-105. doi: 10.1007/s11693-013-9115-5. Epub 2013 Jul 17.

40.

Preserving antibiotics, rationally.

Hollis A, Ahmed Z.

N Engl J Med. 2013 Dec 26;369(26):2474-6. doi: 10.1056/NEJMp1311479. No abstract available.

41.

Funding innovation for treatment for rare diseases: adopting a cost-based yardstick approach.

Fellows GK, Hollis A.

Orphanet J Rare Dis. 2013 Nov 16;8:180. doi: 10.1186/1750-1172-8-180.

42.

The driving competence of 90-year-old drivers: from a hospital-based driving clinic.

Hollis AM, Lee AK, Kapust LR, Phillips LK, Wolkin J, O'Connor MG.

Traffic Inj Prev. 2013;14(8):782-90. doi: 10.1080/15389588.2013.777957.

PMID:
24073765
43.

Can we improve clinical prediction of at-risk older drivers?

Bowers AR, Anastasio RJ, Sheldon SS, O'Connor MG, Hollis AM, Howe PD, Horowitz TS.

Accid Anal Prev. 2013 Oct;59:537-47. doi: 10.1016/j.aap.2013.06.037. Epub 2013 Jul 16.

44.

Current concepts in hypophosphatasia: case report and literature review.

Hollis A, Arundel P, High A, Balmer R.

Int J Paediatr Dent. 2013 May;23(3):153-9. doi: 10.1111/j.1365-263X.2012.01239.x. Epub 2012 Jun 4. Review.

PMID:
22672232
45.

The natural product betulinic acid inhibits C/EBP family transcription factors.

Hollis A, Sperl B, Gräber M, Berg T.

Chembiochem. 2012 Jan 23;13(2):302-7. doi: 10.1002/cbic.201100652. Epub 2011 Dec 23. No abstract available.

PMID:
22213238
46.

Modeling and analysis of work flow and staffing level in a computed tomography division of University of Wisconsin Medical Foundation.

Wang J, Quan S, Li J, Hollis AM.

Health Care Manag Sci. 2012 Jun;15(2):108-20. doi: 10.1007/s10729-011-9188-1. Epub 2011 Nov 30.

PMID:
22127563
47.

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.

Grootendorst P, Bouchard R, Hollis A.

CMAJ. 2012 Mar 20;184(5):543-9. doi: 10.1503/cmaj.110493. Epub 2011 Nov 7. No abstract available.

48.

Epilogue: New drugs for neglected diseases.

Pogge T, Hollis A.

Camb Q Healthc Ethics. 2011 Apr;20(2):329-34. doi: 10.1017/S0963180110000988. No abstract available.

PMID:
21435308
49.

New drug development.

Hoffman SJ, Pogge T, Hollis A.

Lancet. 2011 Mar 12;377(9769):901-2. doi: 10.1016/S0140-6736(11)60347-4. No abstract available.

PMID:
21397761
50.

New approaches to rewarding pharmaceutical innovation.

Grootendorst P, Hollis A, Levine DK, Pogge T, Edwards AM.

CMAJ. 2011 Apr 5;183(6):681-5. doi: 10.1503/cmaj.100375. Epub 2010 Dec 13. No abstract available.

Supplemental Content

Loading ...
Support Center